Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation-Reference-Cited by-同舟云学术

Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation

Published:2018-05 Issue:5 Volume:24 Page:989-996
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Horváth Orsolya,Kállay Krisztián,Csuka Dorottya,Mező Blanka,Sinkovits György,Kassa Csaba,Stréhn Anita,Csordás Katalin,Sinkó János,Prohászka Zoltán,Kriván Gergely

Funder

National Research Fund

Hungarian Academy of Sciences

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Post-bone marrow transplant thrombotic microangiopathy;Obut;Bone Marrow Transplant,2016

2. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma;George;Transfusion,2004

3. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis;Changsirikulchai;Clin J Am Soc Nephrol,2009

4. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults;Jodele;Blood,2014

5. The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy;Balassa;Bone Marrow Transplant,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP;International Journal of Molecular Sciences;2023-09-21

2. Infekciók kockázatának csökkentése veleszületett és szerzett komplementdefektusokban.;Orvosi Hetilap;2023-06-25

3. MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy:in vitroandex vivoevidence;Clinical and Experimental Immunology;2023-05-16

4. Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA);Thrombosis Research;2023-05

5. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis;Clinical and Translational Oncology;2023-03-28